These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 3519270)

  • 1. Immunomodulating peptides.
    Werner GH; Floc'h F; Migliore-Samour D; Jollès P
    Experientia; 1986 May; 42(5):521-31. PubMed ID: 3519270
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biological properties of synthetic glycopeptides stimulating immunogenesis and nonspecific resistance].
    Dzheksenbaev OSh
    Zh Mikrobiol Epidemiol Immunobiol; 1981; (8):13-8. PubMed ID: 7032159
    [No Abstract]   [Full Text] [Related]  

  • 3. Recent developments concerning muramyl dipeptide, a synthetic immunoregulating molecule.
    Chedid L; Carelli C; Audibert F
    J Reticuloendothel Soc; 1979 Dec; 26(Suppl):631-41. PubMed ID: 392087
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunologically active peptides stimulating the T-cell system].
    Chipens GI; Vegner RE
    Ukr Biokhim Zh (1978); 1986; 58(3):91-103. PubMed ID: 3523897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Past, present and future of the synthetic immunoadjuvant MDP and its analogs.
    Chedid L; Lederer E
    Biochem Pharmacol; 1978; 27(18):2183-6. PubMed ID: 365182
    [No Abstract]   [Full Text] [Related]  

  • 6. [Synthetic immunologically active peptides].
    Rong KT
    Sheng Li Ke Xue Jin Zhan; 1986 Jan; 17(1):20-4. PubMed ID: 3526537
    [No Abstract]   [Full Text] [Related]  

  • 7. Developmental status of synthetic immunomodulators.
    Berendt MJ; Ives JL
    Year Immunol; 1985; ():193-201. PubMed ID: 2437723
    [No Abstract]   [Full Text] [Related]  

  • 8. Natural and synthetic peptides (other than neuropeptides) endowed with immunomodulating activities.
    Werner GH
    Immunol Lett; 1987 Dec; 16(3-4):363-70. PubMed ID: 3327819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient genetically controlled formation of antibody to a synthetic antigen [poly(LTyr, LGlu)-poly(DLAla)- -poly(LLys)] covalently bound to a synthetic adjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine).
    Mozes E; Sela M; Chedid L
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4933-7. PubMed ID: 6776530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic use of immunostimulants against infections (author's transl)].
    Lesavre P; Bach JF
    Comp Immunol Microbiol Infect Dis; 1980; 3(4):391-406. PubMed ID: 6162607
    [No Abstract]   [Full Text] [Related]  

  • 11. [Adjuvant activity and adjuvant arthritis].
    Tanaka A
    Kekkaku; 1980 Oct; 55(10):465-7. PubMed ID: 7230587
    [No Abstract]   [Full Text] [Related]  

  • 12. Study of immunomodulatory properties of N-acetylmuramyl-L-alanyl-D-isoglutamine and N-acetylglucosaminyl-(beta 1----4)-N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Dozmorov IM; Kuzin II; Lutsan NI; Lutsenko GV; Prokhorova AL; Sapozhnikov AM; Andronova TM; Ivanov VT
    Biomed Sci; 1991; 2(6):651-8. PubMed ID: 1841635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant activity of nocardomycoloyl derivatives of N-acetylmuramyldipeptide in mice and guinea pigs.
    Saiki I; Uemiya M; Kusama T; Yamamura Y; Azuma I
    Microbiol Immunol; 1980; 24(3):265-9. PubMed ID: 6968020
    [No Abstract]   [Full Text] [Related]  

  • 14. Muramyl peptides. Chemical structure, biological activity and mechanism of action.
    Adam A; Petit JF; Lefrancier P; Lederer E
    Mol Cell Biochem; 1981 Dec; 41():27-47. PubMed ID: 7035868
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunocompetent cells in resistance to bacterial infections.
    Campbell PA
    Bacteriol Rev; 1976 Jun; 40(2):284-313. PubMed ID: 786253
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunoactive peptides].
    Ivanov VT
    Vopr Med Khim; 1984; 30(3):23-31. PubMed ID: 6206648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 1, a mediator of immunoadjuvant peptidoglycans.
    Guenounou M; Vacheron F; Nauciel C
    Comp Immunol Microbiol Infect Dis; 1985; 8(3-4):273-84. PubMed ID: 2868825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fundamental studies to use the adjuvant activity of 6-o-acylmuramyldipeptides to potentiate cell and humoral immune responses for practical purposes].
    Tsujimoto M
    J Osaka Univ Dent Sch; 1981 Jun; 26(1):63-83. PubMed ID: 6945426
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Heymer B; Finger H; Wirsing CH
    Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of certain biological activities of muramyl dipeptide derivatives after conjugation to a multi-poly(DL-alanine)--poly(L-lysine) carrier.
    Chedid L; Parant M; Parant F; Audibert F; Lefrancier F; Choay J; Sela M
    Proc Natl Acad Sci U S A; 1979 Dec; 76(12):6557-61. PubMed ID: 293743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.